SNHG15 promotes chemoresistance and glycolysis in colorectal cancer
Pathology - Research and Practice · 2023-06 · 246 · 154480
DOI: 10.1016/j.prp.2023.154480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023-06. Verfasst von Min Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Wuxi 9th People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu 214100, China. Electronic address: lixiaomin1991@163.…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Long noncoding RNAs (lncRNAs) play an important role in tumor progression. Small nucleolar RNA host gene 15 (SNHG15) is a lncRNA that has been confirmed to play an oncogenic role in multiple cancer types. However, its role in glycolysis and chemoresistance in colorectal cancer (CRC) is unclear. The expression of SNHG15 in CRC was analyzed using data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases by bioinformatics methods. Cell Counting Kit-8 (CCK-8) and colony formation assays were used to evaluate cell viability. Cell sensitivity to 5-fluorouracil (5-FU) was detected by CCK-8. Glucose absorption and lactate production were used to evaluate the impact of SNHG15 on glycolysis. RNA-seq, real-time fluorescence quantitative reverse transcription PCR (RT-qPCR) and Western blotting (WB) were used to reveal the potential molecular mechanism of SNHG15 in CRC. SNHG15 was upregulated in CRC tissues compared with paired noncancerous tissues. Ectopic SNHG15 expression increased proliferation, 5-FU chemoresistance, and glycolysis in CRC cells. In contrast, SNHG15 knockdown inhibited CRC proliferation, 5-FU chemoresistance and glycolysis. Multiple pathways, including apoptosis and glycolysis, were potentially regulated by SNHG15 based on RNA-seq and pathway enrichment analyses. RT-qPCR and WB experiments confirmed that SNHG15 promoted the expression of TYMS, BCL2, GLUT1 and PKM2 in CRC cells. In conclusion, SNHG15 promotes 5-FU chemoresistance and glycolysis in CRC by potentially regulating the expression of TYMS, BCL2, GLUT1 and PKM2 and appears to be a new target for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy Department, Wuxi 9th People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu 214100, China. Electronic address: lixiaomin1991@163.com.
- Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214062, China.
- Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu 214122, China.
- Pharmacy Department, Wuxi 9th People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu 214100, China. Electronic address: youxiaohong0109@126.com.
- Pharmacy Department, Wuxi 9th People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu 214100, China.
Zitieren
APA
Li, M., Sun, S., Bian, Z., Yao, S., Liu, M., You, X., & Li, M. (2023). SNHG15 promotes chemoresistance and glycolysis in colorectal cancer. Pathology - Research and Practice, 246, 154480. https://doi.org/10.1016/j.prp.2023.154480
Vancouver
Li M, Sun S, Bian Z, Yao S, Liu M, You X, et al. SNHG15 promotes chemoresistance and glycolysis in colorectal cancer. Pathology - Research and Practice. 2023;246:154480. doi:10.1016/j.prp.2023.154480
BibTeX
@article{Li2023,
author = {Li, Min and Sun, Shengbai and Bian, Zehua and Yao, Surui and Liu, Meng and You, Xiaohong and Li, Min},
title = {SNHG15 promotes chemoresistance and glycolysis in colorectal cancer},
journal = {Pathology - Research and Practice},
year = {2023},
volume = {246},
pages = {154480},
doi = {10.1016/j.prp.2023.154480}
}
EUVIMED